Alumis, Inc. (ALMS)
25.50
-0.62
(-2.39%)
USD |
NASDAQ |
May 06, 16:00
25.50
0.00 (0.00%)
After-Hours: 16:07
Alumis Profit Margin (Quarterly) : -4.82K% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 23.31% |
| Nektar Therapeutics | -165.4% |
| Oramed Pharmaceuticals, Inc. | -- |
| Aclaris Therapeutics, Inc. | -1.53K% |
| Crinetics Pharmaceuticals, Inc. | -1.99K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -76.05% |
| Return on Assets | -57.46% |
| Return on Invested Capital | -68.51% |
| Gross Profit Margin (Quarterly) | 55.05% |
| Operating Margin (Quarterly) | -4.38K% |
| Return on Net Operating Assets | -304.8% |